$SGRY
Surgery Partners, Inc. Stock $sgry

$sgry Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000163883320000073 Filed on November 04, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$548.3M	$496.1M	$452.0M
YoY Change	6.01%	9.76%	4.53%
Cost Of Revenue	$390.2M	$360.0M	$353.1M
YoY Change	0.57%	1.95%	5.62%
Gross Profit	$158.1M	$136.1M	$98.90M
YoY Change	22.37%	37.61%	0.82%
Gross Profit Margin	28.83%	27.43%	21.88%
Selling, General & Admin	$46.50M	$47.10M	$41.30M
YoY Change	0.43%	14.04%	0.49%
% of Gross Profit	29.41%	34.61%	41.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$25.50M	$24.10M	$18.40M
YoY Change	26.24%	30.98%	8.24%
% of Gross Profit	16.13%	17.71%	18.6%
Operating Expenses	$72.00M	$477.6M	$393.0M
YoY Change	8.27%	21.53%	1.45%
Operating Profit	$86.10M	$18.50M	$59.00M
YoY Change	37.32%	-68.64%	31.11%
Interest Expense	-$50.80M	-$51.50M	-$45.70M
YoY Change	23.3%	12.69%	22.85%
% of Operating Profit	-59.0%	-278.38%	-77.46%
Other Income/Expense, Net	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Pretax Income	$42.30M	-$33.00M	$13.30M
YoY Change	56.67%	-348.12%	70.51%
Income Tax	-$5.600M	$1.300M	$2.400M
% Of Pretax Income	-13.24%		18.05%
Net Earnings	$5.500M	-$61.60M	-$15.70M
YoY Change	-128.65%	292.36%	-25.24%
Net Earnings / Revenue	1.0%	-12.42%	-3.47%
Basic Earnings Per Share		-$1.46	-$0.51
Diluted Earnings Per Share	$112.5K	-$1.46	-$0.51
COMMON SHARES
Basic Shares Outstanding	50.49M shares	48.88M shares	48.31M shares
Diluted Shares Outstanding		48.88M shares	48.31M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$317.9M	$450.0M	$111.3M
YoY Change	242.93%	304.31%	40.71%
Cash & Equivalents	$317.9M	$450.0M	$111.3M
Short-Term Investments
Other Short-Term Assets	$27.40M	$36.30M	$49.90M
YoY Change	-34.45%	-27.25%	-6.9%
Inventory	$56.40M	$50.90M	$44.40M
Prepaid Expenses	$17.60M	$19.20M
Receivables	$382.2M	$337.0M	$303.1M
Other Receivables	$0.00	$9.700M	$9.200M
Total Short-Term Assets	$801.5M	$893.4M	$517.9M
YoY Change	52.52%	72.5%	11.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$854.7M	$812.6M	$719.9M
YoY Change	4.1%	12.88%	71.4%
Goodwill	$3.468B	$3.345B	$3.406B
YoY Change	1.93%	-1.79%	0.98%
Intangibles	$46.90M		$52.60M
YoY Change	-0.85%		-5.41%
Long-Term Investments	$90.60M	$92.10M	$93.30M
YoY Change	-3.1%	-1.29%	15.47%
Other Assets	$27.00M	$20.20M	$344.1M
YoY Change	-12.34%	-94.13%	767.3%
Total Long-Term Assets	$4.612B	$4.420B	$4.400B
YoY Change	2.63%	0.45%	7.43%
TOTAL ASSETS
Total Short-Term Assets	$801.5M	$893.4M	$517.9M
Total Long-Term Assets	$4.612B	$4.420B	$4.400B
Total Assets	$5.413B	$5.313B	$4.918B
YoY Change	7.86%	8.04%	7.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$100.2M	$90.30M	$85.10M
YoY Change	3.62%	6.11%	10.55%
Accrued Expenses	$223.4M	$278.1M	$227.1M
YoY Change	-2.4%	22.46%	67.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$64.40M	$61.10M	$51.30M
YoY Change	15.0%	19.1%	-15.76%
Total Short-Term Liabilities	$556.8M	$590.9M	$381.5M
YoY Change	39.86%	54.89%	29.07%
LONG-TERM LIABILITIES
Long-Term Debt	$2.792B	$2.761B	$2.403B
YoY Change	10.6%	14.91%	6.48%
Other Long-Term Liabilities	$139.7M	$124.9M	$426.3M
YoY Change	22.98%	-70.7%	72.37%
Total Long-Term Liabilities	$139.7M	$124.9M	$426.3M
YoY Change	22.98%	-70.7%	72.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$556.8M	$590.9M	$381.5M
Total Long-Term Liabilities	$139.7M	$124.9M	$426.3M
Total Liabilities	$696.5M	$715.8M	$807.8M
YoY Change	36.11%	-11.39%	48.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$431.8M		-$284.6M
YoY Change	36.78%		186.66%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$115.6M	$101.2M	$328.7M
YoY Change
Total Liabilities & Shareholders Equity	$5.413B	$5.313B	$4.918B
YoY Change	7.86%	8.04%	7.87%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	$5.500M	-$61.60M	-$15.70M
YoY Change	-128.65%	292.36%	-25.24%
Depreciation, Depletion And Amortization	$25.50M	$24.10M	$18.40M
YoY Change	26.24%	30.98%	8.24%
Cash From Operating Activities	$8.900M	$26.90M	$56.90M
YoY Change	-64.96%	-52.72%	92.88%
INVESTING ACTIVITIES
Capital Expenditures	-$15.10M	-$7.900M	-$18.40M
YoY Change	-35.47%	-57.07%	71.96%
Acquisitions
YoY Change
Other Investing Activities	-$80.10M	$37.20M	-$500.0K
YoY Change		-7540.0%	-54.55%
Cash From Investing Activities	-$95.20M	$29.30M	-$18.90M
YoY Change	306.84%	-255.03%	60.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-45.80M	67.50M	-44.10M
YoY Change	122.33%	-253.06%	27.83%
NET CHANGE
Cash From Operating Activities	8.900M	26.90M	56.90M
Cash From Investing Activities	-95.20M	29.30M	-18.90M
Cash From Financing Activities	-45.80M	67.50M	-44.10M
Net Change In Cash	-132.1M	123.7M	-6.100M
YoY Change	610.22%	-2127.87%	-63.69%
FREE CASH FLOW
Cash From Operating Activities	$8.900M	$26.90M	$56.90M
Capital Expenditures	-$15.10M	-$7.900M	-$18.40M
Free Cash Flow	$24.00M	$34.80M	$75.30M
YoY Change	-50.82%	-53.78%	87.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Registrant Name EntityRegistrantName	Surgery Partners, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001638833
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:LongTermDebtAndCapitalLeaseObligations
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:LongTermDebtAndCapitalLeaseObligations
CY2020Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2019Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37576
	dei	Trading Symbol TradingSymbol	SGRY
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	450000000.0	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92700000	USD
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3620923
	dei	Entity Address Address Line1 EntityAddressAddressLine1	310 Seven Springs Way, Suite 500
	dei	Entity Address City Or Town EntityAddressCityOrTown	Brentwood
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37027
	dei	City Area Code CityAreaCode	615
	dei	Local Phone Number LocalPhoneNumber	234-5900
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50494790	shares
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	337000000.0	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	326900000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	50900000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	46300000	USD
CY2020Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	19200000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17800000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	36300000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	41800000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	893400000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	525500000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	170700000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	110700000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	497700000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	523300000	USD
CY2020Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3389400000	USD
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3449700000	USD
CY2020Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	91800000	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	93200000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	314900000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	297700000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	105500000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	98700000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	20200000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	30800000	USD
CY2020Q3	us-gaap	Assets Assets	5312900000	USD
CY2019Q4	us-gaap	Assets Assets	5018900000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	90300000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	96700000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	65600000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	54200000	USD
CY2020Q3	sgry	Medicare Accelerated Payments And Deferred Governmental Grants Current MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent	141000000.0	USD
CY2019Q4	sgry	Medicare Accelerated Payments And Deferred Governmental Grants Current MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent	0	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	232900000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	191200000	USD
CY2020Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	61100000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	56000000.0	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	590900000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	398100000	USD
CY2020Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2761300000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.185
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2524700000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	306100000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	283100000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	124900000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	113600000	USD
CY2020Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	304700000	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	321000000.0	USD
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	310000	shares
CY2019Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	310000	shares
CY2019Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	310000	shares
CY2020Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	310000	shares
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	310000	shares
CY2020Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	310000	shares
CY2020Q3	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Redemption Value RedeemableNoncontrollingInterestEquityPreferredRedemptionValue	424200000	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Redemption Value RedeemableNoncontrollingInterestEquityPreferredRedemptionValue	395000000.0	USD
CY2020Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	424200000	USD
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	395000000.0	USD
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50494605	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50494605	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49298940	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49298940	shares
CY2020Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	500000	USD
CY2019Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	500000	USD
CY2020Q3	sgry	Other Stockholders Equity Attributable To Parent OtherStockholdersEquityAttributableToParent	100700000	USD
CY2019Q4	sgry	Other Stockholders Equity Attributable To Parent OtherStockholdersEquityAttributableToParent	296300000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	101200000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	296800000	USD
CY2020Q3	us-gaap	Minority Interest MinorityInterest	699600000	USD
	us-gaap	Supplies Expense SuppliesExpense	364600000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	686600000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	800800000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	983400000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5312900000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5018900000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	496100000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	452000000.0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1311800000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1314200000	USD
CY2020Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	141700000	USD
CY2019Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	139300000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	398200000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	401200000	USD
CY2020Q3	us-gaap	Supplies Expense SuppliesExpense	142800000	USD
CY2019Q3	us-gaap	Supplies Expense SuppliesExpense	126200000	USD
	us-gaap	Supplies Expense SuppliesExpense	382200000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1200000	USD
	us-gaap	Professional Fees ProfessionalFees	138400000	USD
	us-gaap	Professional Fees ProfessionalFees	110000000.0	USD
CY2020Q3	us-gaap	Professional Fees ProfessionalFees	46300000	USD
CY2019Q3	us-gaap	Professional Fees ProfessionalFees	38500000	USD
	sgry	Effective Income Tax Rate Reconciliation Coronavirus Aid Reliefand Economic Security Act Cares Act EffectiveIncomeTaxRateReconciliationCoronavirusAidReliefandEconomicSecurityActCARESAct	-6900000	USD
CY2020Q3	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	21900000	USD
CY2019Q3	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	21400000	USD
	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	64700000	USD
	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	63000000.0	USD
CY2020Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	29200000	USD
CY2019Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	27700000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	83900000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	80800000	USD
CY2020Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	381900000	USD
CY2019Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	353100000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1067400000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1019600000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25200000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19900000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	73300000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	64900000	USD
CY2020Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24100000	USD
CY2019Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18400000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	69300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	56300000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3100000	USD
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2400000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7600000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6600000	USD
CY2020Q3	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-700000	USD
CY2019Q3	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-600000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-7100000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	7000000.0	USD
CY2020Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	5400000	USD
CY2019Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	3400000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	15800000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	11600000	USD
CY2020Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	33500000	USD
CY2019Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	33500000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q3	sgry	Grant Revenue GrantRevenue	-9900000	USD
CY2019Q3	sgry	Grant Revenue GrantRevenue	0	USD
	sgry	Grant Revenue GrantRevenue	33200000	USD
	sgry	Grant Revenue GrantRevenue	0	USD
CY2020Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2019Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1200000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11700000	USD
CY2020Q3	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	0	USD
CY2019Q3	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	0	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-1700000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-400000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	477600000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	393000000.0	USD
	us-gaap	Operating Expenses OperatingExpenses	1225100000	USD
	us-gaap	Operating Expenses OperatingExpenses	1150100000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	18500000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	59000000.0	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	86700000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	164100000	USD
CY2020Q3	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
CY2019Q3	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	2400000	USD
CY2020Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-51500000	USD
CY2019Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-45700000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-147800000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-134100000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-33000000.0	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	13300000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-61100000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	27600000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1300000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-14500000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5100000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-34300000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	10900000	USD
	us-gaap	Profit Loss ProfitLoss	-46600000	USD
	us-gaap	Profit Loss ProfitLoss	22500000	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	27300000	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	26600000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	75000000.0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	78100000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-61600000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-15700000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-121600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-55600000	USD
CY2020Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	10000000.0	USD
CY2019Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	9100000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	29200000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	26400000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-71600000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24800000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-150800000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-82000000.0	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.46
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.70
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.46
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.70
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48883000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48310000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48736000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48265000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48883000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48310000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48736000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48265000	shares
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-34300000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	10900000	USD
	us-gaap	Profit Loss ProfitLoss	-46600000	USD
	us-gaap	Profit Loss ProfitLoss	22500000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	3300000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-6800000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-14600000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-35100000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-31000000.0	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	4100000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-61200000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12600000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	27300000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	26600000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	75000000.0	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	78100000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-58300000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22500000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-136200000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-90700000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	983400000	USD
CY2020Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-13900000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2800000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	9500000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-25200000	USD
CY2020Q1	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	700000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	14900000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	923400000	USD
CY2020Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-9700000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3800000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	9700000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	7300000	USD
CY2020Q2	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	1700000	USD
CY2020Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	20900000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	895900000	USD
CY2020Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-42300000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3000000.0	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	10000000.0	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	3300000	USD
CY2020Q3	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	-30300000	USD
CY2020Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	18800000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	800800000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1098900000	USD
CY2019Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-4100000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	900000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	8500000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-11500000	USD
CY2019Q1	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	14100000	USD
	us-gaap	Income Tax Reconciliation Tax Settlements IncomeTaxReconciliationTaxSettlements	-5000000.0	USD
CY2019Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	23500000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1084300000	USD
CY2019Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-1100000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3100000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	8800000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-16800000	USD
CY2019Q2	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	2000000.0	USD
CY2019Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	17700000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1045000000.0	USD
CY2019Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	3600000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2700000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	9100000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-6800000	USD
CY2019Q3	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	-9000000.0	USD
CY2019Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	19900000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1006500000	USD
	us-gaap	Profit Loss ProfitLoss	-46600000	USD
	us-gaap	Profit Loss ProfitLoss	22500000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	69300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	56300000	USD
	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-3100000	USD
	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-600000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9900000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7600000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-7100000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	7000000.0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	33500000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11700000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15300000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4100000	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	1000000.0	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-500000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	29400000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	28800000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11900000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7700000	USD
	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	141000000.0	USD
	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	0	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-19500000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	28700000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	238000000.0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	104100000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27800000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	50200000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	14200000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	13800000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	48300000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	17600000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	15200000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-500000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	200000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6800000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61800000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	197300000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	436100000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	428000000.0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	442500000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8300000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8800000	USD
	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	0	USD
	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	17800000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	82300000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	89500000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	27300000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	4600000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-300000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000.0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	112500000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-115300000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	357300000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-73000000.0	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93000000.0	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184600000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	450300000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111600000	USD
CY2020Q3	sgry	Number Of Surgical Facilities Owned NumberOfSurgicalFacilitiesOwned	126	surgical_facilities
CY2020Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	30	state
CY2020Q3	sgry	Number Of Surgical Facilities Owned Majority Interest NumberOfSurgicalFacilitiesOwnedMajorityInterest	84	surgical_facilities
CY2020Q3	sgry	Number Of Surgical Facilities Owned Consolidated NumberOfSurgicalFacilitiesOwnedConsolidated	106	surgical_facilities
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1311800000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	5000000.0	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div>
	sgry	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	53000000	USD
CY2020Q3	sgry	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	5000000	USD
	sgry	Grant Revenue GrantRevenue	43100000	USD
CY2020Q3	sgry	Grant Revenue GrantRevenue	-9900000	USD
	sgry	Grant Revenue GrantRevenue	33200000	USD
	sgry	Coronavirus Aid Reliefand Economic Security Act Cares Act Government Grant Received Accelerated Payments CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments	120000000	USD
CY2020Q3	sgry	Coronavirus Aid Reliefand Economic Security Act Cares Act Government Grant Received Accelerated Payments CoronavirusAidReliefandEconomicSecurityActCARESActGovernmentGrantReceivedAcceleratedPayments	0	USD
CY2020Q3	sgry	Deferred Employee Related Liabilities Current DeferredEmployeeRelatedLiabilitiesCurrent	7300000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1314200000	USD
CY2020Q3	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	4	surgical_facilities
CY2020Q3	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	3	physician_practice
CY2020Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	65300000	USD
CY2019Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	50700000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	496100000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	452000000.0	USD
CY2019Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	300000	USD
CY2020Q3	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	300000	USD
CY2020Q3	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	15700000	USD
CY2019Q4	sgry	Third Party Settlements Payable Current ThirdPartySettlementsPayableCurrent	5600000	USD
CY2020Q3	sgry	Optical Products Receivable OpticalProductsReceivable	9700000	USD
CY2019Q4	sgry	Optical Products Receivable OpticalProductsReceivable	8600000	USD
CY2019Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	314500000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.237
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	321000000.0	USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	326600000	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	19300000	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	24100000	USD
	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	-7900000	USD
	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	-7800000	USD
	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	27700000	USD
	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	28400000	USD
CY2020Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	304700000	USD
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	56000000.0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	3402400000	USD
	sgry	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	26400000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	24900000	USD
	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	49200000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	33500000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	3344600000	USD
CY2020Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	242700000	USD
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	253400000	USD
CY2020Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	16800000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	10800000	USD
CY2020Q3	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	2822400000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	2580700000	USD
CY2020Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	61100000	USD
CY2020Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2761300000	USD
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2524700000	USD
	sgry	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	26400000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	54900000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	50800000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	19000000.0	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	15300000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	15700000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	10900000	USD
	sgry	Finance Lease Cost FinanceLeaseCost	34700000	USD
	sgry	Finance Lease Cost FinanceLeaseCost	26200000	USD
	sgry	Variable And Short Term Lease Cost VariableAndShortTermLeaseCost	12600000	USD
	sgry	Variable And Short Term Lease Cost VariableAndShortTermLeaseCost	10600000	USD
	us-gaap	Lease Cost LeaseCost	102200000	USD
	us-gaap	Lease Cost LeaseCost	87600000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	49800000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	48700000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	15700000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	10900000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	12900000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	9400000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	53900000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	48000000.0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	11500000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	9100000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	1700000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	14600000	USD
	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	0
CY2019Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2020Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	-21800000	USD
CY2020Q3	us-gaap	Number Of Interest Rate Derivatives Held NumberOfInterestRateDerivativesHeld	4	swap
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	2300000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	8500000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	29200000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	39600000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	5600000	USD
CY2020Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	60100000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	4500000	USD
CY2020Q3	us-gaap	Self Insurance Reserve SelfInsuranceReserve	21800000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-61600000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-15700000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-121600000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-55600000	USD
CY2020Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	10000000.0	USD
CY2019Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	9100000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	29200000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	26400000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-71600000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24800000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-150800000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-82000000.0	USD
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48883000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48310000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48736000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48265000	shares
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.46
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.51
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.09
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.70
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38300000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37300000	USD
CY2020Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	32300000	USD
CY2019Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	35100000	USD
CY2020Q3	us-gaap	Interest Payable Current InterestPayableCurrent	31800000	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	21800000	USD
CY2020Q3	srt	Payables To Customers PayablesToCustomers	20400000	USD
CY2019Q4	srt	Payables To Customers PayablesToCustomers	16500000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	110100000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	80500000	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	232900000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	191200000	USD
CY2019Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	19400000	USD
CY2019Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	12100000	USD
CY2020Q3	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	12100000	USD
CY2020Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	40000000.0	USD
CY2020Q2	sgry	Litigation Settlement Interest Percentage LitigationSettlementInterestPercentage	0.0275
CY2020Q2	sgry	Litigation Settlement Amount Awardedfrom Other Party Approved Paid Claims LitigationSettlementAmountAwardedfromOtherPartyApprovedPaidClaims	7500000	USD
CY2020Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	1800000	USD
CY2020Q2	sgry	Litigation Settlement Payment Schedule Period Post Settlement Agreement Date Number Of Business Days LitigationSettlementPaymentSchedulePeriodPostSettlementAgreementDateNumberOfBusinessDays	20	business_day
CY2018	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-46000000.0	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1200000	USD
	sgry	Collaborative Tax Agreement Projected Tax Savings Term CollaborativeTaxAgreementProjectedTaxSavingsTerm	P5Y
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.24
CY2019Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	60100000	USD
CY2020Q3	sgry	Deferred Income Tax Liabilities Net Of Discount DeferredIncomeTaxLiabilitiesNetOfDiscount	52500000	USD
CY2019Q4	sgry	Deferred Income Tax Liabilities Net Of Discount DeferredIncomeTaxLiabilitiesNetOfDiscount	48700000	USD
CY2020Q3	sgry	Deferred Income Tax Liabilities Net Of Discount Current DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent	16900000	USD
CY2019Q4	sgry	Deferred Income Tax Liabilities Net Of Discount Current DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent	16900000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	496100000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	452000000.0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1311800000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1314200000	USD
CY2020Q3	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	61100000	USD
CY2019Q3	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	62200000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	165800000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	174200000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-33000000.0	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	13300000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-61100000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	27600000	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	27300000	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	26600000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	75000000.0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	78100000	USD
CY2020Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24100000	USD
CY2019Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18400000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	69300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	56300000	USD
CY2020Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-51500000	USD
CY2019Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-45700000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-147800000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-134100000	USD
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	3000000.0	USD
CY2019Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2700000	USD
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	3700000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9900000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7600000	USD
CY2020Q3	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	7500000	USD
CY2019Q3	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	5300000	USD
	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	30200000	USD
	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	16800000	USD
CY2020Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	33500000	USD
CY2019Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	33500000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q3	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-700000	USD
CY2019Q3	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-600000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-7100000	USD
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	7000000.0	USD
CY2020Q3	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	-1100000	USD
CY2019Q3	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	-2800000	USD
CY2019Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2800000	USD
	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	-4900000	USD
	sgry	Gain Loss Relatedto Litigation Settlement And Other Litigation Costs GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts	-2800000	USD
CY2020Q3	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	0	USD
CY2019Q3	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	0	USD
	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	-800000	USD
	sgry	Business Combination Gain Loss On Acquisition Escrow BusinessCombinationGainLossOnAcquisitionEscrow	0	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11700000	USD
CY2020Q3	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
CY2019Q3	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	0	USD
	sgry	Tax Receivable Agreement Expense Benefit TaxReceivableAgreementExpenseBenefit	2400000	USD
CY2020Q3	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	61100000	USD
CY2019Q3	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	62200000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	165800000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	174200000	USD
CY2020Q3	sgry	Grant Revenue Attributable To Parent GrantRevenueAttributableToParent	5400000	USD
CY2019Q3	sgry	Grant Revenue Attributable To Parent GrantRevenueAttributableToParent	0	USD
	sgry	Grant Revenue Attributable To Parent GrantRevenueAttributableToParent	-21900000	USD
	sgry	Grant Revenue Attributable To Parent GrantRevenueAttributableToParent	0	USD
CY2020Q3	sgry	Earnings Before Interest Taxes Depreciation And Amortization Excluding Grant Revenue EarningsBeforeInterestTaxesDepreciationAndAmortizationExcludingGrantRevenue	66500000	USD
CY2019Q3	sgry	Earnings Before Interest Taxes Depreciation And Amortization Excluding Grant Revenue EarningsBeforeInterestTaxesDepreciationAndAmortizationExcludingGrantRevenue	62200000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization Excluding Grant Revenue EarningsBeforeInterestTaxesDepreciationAndAmortizationExcludingGrantRevenue	143900000	USD
	sgry	Earnings Before Interest Taxes Depreciation And Amortization Excluding Grant Revenue EarningsBeforeInterestTaxesDepreciationAndAmortizationExcludingGrantRevenue	174200000	USD
CY2020Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	5400000	USD
CY2019Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	3400000	USD
CY2020Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2100000	USD
CY2019Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1900000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	15800000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	11600000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	14400000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	5200000	USD
CY2020Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1100000	USD
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2800000	USD
CY2020Q3	us-gaap	Assets Assets	5312900000	USD
CY2019Q4	us-gaap	Assets Assets	5018900000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27800000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	50200000	USD

Files In Submission

Name	View Source	Status
0001638833-20-000073-index-headers.html	Edgar Link	pending
0001638833-20-000073-index.html	Edgar Link	pending
0001638833-20-000073.txt	Edgar Link	pending
0001638833-20-000073-xbrl.zip	Edgar Link	pending
a2020q3exhibit311.htm	Edgar Link	pending
a2020q3exhibit312.htm	Edgar Link	pending
a2020q3exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgry-20200930.htm	Edgar Link	pending
sgry-20200930.xsd	Edgar Link	pending
sgry-20200930_cal.xml	Edgar Link	unprocessable
sgry-20200930_def.xml	Edgar Link	unprocessable
sgry-20200930_htm.xml	Edgar Link	completed
sgry-20200930_lab.xml	Edgar Link	unprocessable
sgry-20200930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGRY
Surgery Partners, Inc. Stock $sgry

2020 Q4 Form 10-Q Financial Statement

#000163883320000073 Filed on November 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY Surgery Partners, Inc. Stock $sgry

2020 Q4 Form 10-Q Financial Statement

#000163883320000073 Filed on November 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY
Surgery Partners, Inc. Stock $sgry